Estimaciones de analistas de Wall Street para Mustang Bio, Inc. (MBIO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 7 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 7 |
| Calificación media (1-5) | 1.00 |
Ratios de valoración
| Precio / Valor contable | 0.45 |
| EV / EBITDA | 3.64 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $2000 | $630000 | $1.4M | $1.8M | $2.3M | $3.0M | $2.2M | 0 | $41000 |
| Beneficio Bruto | 0 | -$2000 | -$630000 | -$1.4M | -$1.8M | -$2.3M | -$3.0M | -$2.2M | 0 | -$41000 |
| I+D | $8.5M | $20.4M | $24.5M | $36.3M | $45.6M | $53.5M | $63.9M | $39.2M | $8.4M | $1.5M |
| Generales y Administrativos | $2.8M | $11.4M | $6.8M | $9.6M | $9.5M | $11.0M | $12.2M | $9.3M | $4.1M | $3.9M |
| Gastos Operativos | $11.4M | $31.8M | $31.2M | $45.9M | $55.0M | $64.4M | $73.1M | $48.5M | $16.2M | $2.4M |
| Beneficio Operativo | $11.4M | -$31.8M | -$31.2M | -$45.9M | -$56.8M | -$66.7M | -$76.2M | -$50.7M | -$16.2M | -$2.4M |
| EBITDA | -$11.5M | -$31.3M | -$30.0M | -$43.3M | -$54.3M | -$64.0M | -$71.1M | -$48.1M | -$14.9M | -$1.9M |
| Gastos por Intereses | $1.1M | $8000 | $8000 | $1.8M | $3.9M | $15000 | $3.4M | $1.3M | -$5000 | 0 |
| Beneficio Antes de Impuestos | -$12.7M | -$31.3M | -$30.7M | -$46.4M | -$60.0M | -$66.4M | -$77.5M | -$51.6M | -$15.8M | -$1.9M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$12.7M | -$31.3M | -$30.7M | -$48.2M | -$60.0M | -$66.4M | -$77.5M | -$51.6M | -$15.8M | -$1.9M |
| BPA | $-7.24 | $-18.58 | $-17.07 | $-20.03 | $-17.10 | $-11.40 | $-11.25 | $-6.00 | $-2.57 | $-0.39 |
| BPA Diluido | $-7.24 | $-18.58 | $-17.07 | $-20.03 | $-17.10 | $-11.40 | $-11.25 | $-6.00 | $-2.57 | $-0.39 |
| Acciones en Circulación (Diluidas) | $1.7M | $1.7M | $1.8M | $2.4M | $3.5M | $5.9M | $6.9M | $8.6M | $6.1M | $4.9M |
Precio
| Precio | $0.50 |
| Capitalización | $4M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABP · ACXP · BOLT · DWTX · EVGN · IMRN · LYRA
Explorar sector: Healthcare · Biotechnology
Más secciones de MBIO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones